Pictet Asset Management Sa Blueprint Medicines Corp Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pictet Asset Management Sa holds 723,766 shares of BPMC stock, worth $93.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
723,766
Previous 573,644
26.17%
Holding current value
$93.6 Million
Previous $25.8 Million
77.24%
% of portfolio
0.05%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding BPMC
# of Institutions
388Shares Held
68.4MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$860 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$859 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$701 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$498 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$398 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...